Chronic administration of therapeutic levels of clenbuterol acts as a repartitioning agent

Journal of Applied Physiology

Volumn 91, Issue 5, 2001, Pages 2064-2070

  Kearns, Charles F ^a   McKeever, Kenneth H ^a,c   Malinowski, Karyn ^a   Struck, Maggie B ^a   Takashi, A B E ^b  

^a The State University of New Jersey   (United States)

^b TOKYO METROPOLITAN UNIVERSITY   (Japan)

^c Equine Exercise Physiol Laboratory   (United States)

Author keywords

Equine; Ultrasound; 2 agonist

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; FAT; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B SCAN; BETA ADRENERGIC STIMULATION; BODY COMPOSITION; BODY DISTRIBUTION; BODY FAT; CONTROLLED STUDY; DRUG MECHANISM; EXERCISE; HORSE; LEAN BODY WEIGHT; LONG TERM EXPOSURE; MALE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; TRAINING;

EID: 0034750183     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.2001.91.5.2064     Document Type: Article

References (46)

1. Use of a β-adrenergic agonist to alter muscle and fat deposition in lambs
2. Decreased myofibrillar protein breakdown following treatment with clenbuterol
3. β-Adrenergic regulation of a myocardial actic gene via a cyclic AMP-independent pathway
4. Effects of adrenergic activators and inhibitors on the skeletal muscles
5. Skeletal muscle protein synthesis and growth hormone secretion in young lambs treated with clenbuterol
6. A repartitioning agent to improve performance and carcass composition in broilers
7. Deleterious effects of chronic clenbuterol treatment on endurance and sprint exercise performance in rats
8. Chronic effects of β2-adrenergic agonist on body composition and protein synthesis in the rat
9. Clinical efficacy and safety of clenbuterol HCl when administered to effect in horses with chronic obstructive pulmonary disease (COPD)
10. 2+-independent kinase activity increases during either hypertrophy or running
11. Evaluation of commercially available ELISA test kits for the detection of clenbuterol and other β2-agonist
12. Relationship between condition score, physical measurements and body fat percentages in mares
13. Regulation of hormone-sensative lipase activity in adipose tissue
14. Interaction between clenbuterol and run training: Effects on exercise perfromance and MLC isoform content
15. Clenbuterol plasma concentrations after repeated oral administration and its effects on cardio-respiratory and blood lactate responses to exercise in healthy Standardbred horses
16. Estimating fatness in horses
17. Using body composition as a predictive measure of elite Standardbred perfomance
18. Mucociliary transport rate in the horse and its modification with various phamacologic agents
19. The effect of clenbuterol chloride on the mucociliary transport rate in horses with a clinical diagnosis of chronic obstructive pulmonary disease (COPD)
20. Effects of clenbuterol, ICII 18551 and sotalol on the growth of cardiac and skeletal muscle and on β2-adrenoceptor density in female rats
21. Year-long clenbuterol treatment of mice increases mass, but not specific force or normalized power, of skeletal muscles
22. Effects of clenbuterol and propanol on muscle mass
23. The effect of the anabolic agent, clenbuterol, on overloaded rat skeletal muscle
24. The action of β-agonist clenbuterol on protein metabolism in innervated and denervated phasic muscle
25. Functions of central nervous system neurotransmitters in regulation of growth hormone secretion
26. Effects of sympathomimetic and sympatholytic drugs on exercise performance
27. Calcium/calmodulin-dependent protein kinases
28. Effect of endurance training on β-adrenergic system in three different skeletal muscles
29. Effects of mode of training on cardiovascular function and body composition of adult men
30. Clenbuterol: A substitute for anabolic steroids?
31. Down-regulation of β-adrenergic receptors and up-regulation of estrogen and progesterone induced in the reproductive system of female veal calves by dietary clenbuterol
32. Stimulation of muscle growth by clenbuterol: Lack of effect on muscle protein biosynthesis
33. Use of a β-agonist to alter fat and muscle deposition in steers
34. Clenbuterol and the horse
35. Effects of clenbuterol hydrochloride on certain respiratory and cardiovascular parameters in horses performing treadmill exercise
36. Cardiorespiratory effects of clenbuterol in fit Thoroughbred horses during a maximal exercise test
37. NAB 365, a β2 receptor sympathomimetic agent: Clinical experience in horses with lung disease
38. Molecular mechanisms of β-adrenergic receptor desensitization
39. Respiratory mechanics of horses during stepwise treadmill exercise tests, and the effect of clenbuterol pretreatment on them
40. Hormonal regulation of hormone-sensitive lipase in intact adipocytes: Identification of phosphorlytated sites and effects on the phosphorylation by lipolytic of hormones and insulin
41. Effects of isoprenaline on contractions of directly stimulated fast and slow skeletal muscles of the guinea pig
42. Fiber typespecific effects of clenbuterol and exercise training on insulin-resistant muscle
43. Estimating fatness in horses and ponies
44. Skeletal muscle β-adrenergic receptors: Variations due to fiber type and training
45. Multiple actions of β-adrenergic agonists on skeletal muscle and adipose tissue